Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Archetypal Analysis of Injury in Kidney Transplant Biopsies Identifies Two Classes of Early AKI

PF. Halloran, GA. Böhmig, J. Bromberg, G. Einecke, FA. Eskandary, G. Gupta, M. Myslak, O. Viklicky, A. Perkowska-Ptasinska, KS. Madill-Thomsen, INTERCOMEX Investigators

. 2022 ; 9 (-) : 817324. [pub] 20220407

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22017409

All transplanted kidneys are subjected to some degree of injury as a result of the donation-implantation process and various post-transplant stresses such as rejection. Because transplants are frequently biopsied, they present an opportunity to explore the full spectrum of kidney response-to-wounding from all causes. Defining parenchymal damage in transplanted organs is important for clinical management because it determines function and survival. In this study, we classified the scenarios associated with parenchymal injury in genome-wide microarray results from 1,526 kidney transplant indication biopsies collected during the INTERCOMEX study. We defined injury groups by using archetypal analysis (AA) of scores for gene sets and classifiers previously identified in various injury states. Six groups and their characteristics were defined in this population: No injury, minor injury, two classes of acute kidney injury ("AKI," AKI1, and AKI2), chronic kidney disease (CKD), and CKD combined with AKI. We compared the two classes of AKI, namely, AKI1 and AKI2. AKI1 had a poor function and increased parenchymal dedifferentiation but minimal response-to-injury and inflammation, instead having increased expression of PARD3, a gene previously characterized as being related to epithelial polarity and adherens junctions. In contrast, AKI2 had a poor function and increased response-to-injury, significant inflammation, and increased macrophage activity. In random forest analysis, the most important predictors of function (estimated glomerular filtration rate) and graft loss were injury-based molecular scores, not rejection scores. AKI1 and AKI2 differed in 3-year graft survival, with better survival in the AKI2 group. Thus, injury archetype analysis of injury-induced gene expression shows new heterogeneity in kidney response-to-wounding, revealing AKI1, a class of early transplants with a poor function but minimal inflammation or response to injury, a deviant response characterized as PC3, and an increased risk of failure. Given the relationship between parenchymal injury and kidney survival, further characterization of the injury phenotypes in kidney transplants will be important for an improved understanding that could have implications for understanding native kidney diseases (ClinicalTrials.gov #NCT01299168).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017409
003      
CZ-PrNML
005      
20220720100221.0
007      
ta
008      
220718s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fmed.2022.817324 $2 doi
035    __
$a (PubMed)35463013
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Halloran, Philip F $u Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada $u Division of Nephrology and Transplant Immunology, Department of Medicine, University of Alberta, Edmonton, AB, Canada
245    10
$a Archetypal Analysis of Injury in Kidney Transplant Biopsies Identifies Two Classes of Early AKI / $c PF. Halloran, GA. Böhmig, J. Bromberg, G. Einecke, FA. Eskandary, G. Gupta, M. Myslak, O. Viklicky, A. Perkowska-Ptasinska, KS. Madill-Thomsen, INTERCOMEX Investigators
520    9_
$a All transplanted kidneys are subjected to some degree of injury as a result of the donation-implantation process and various post-transplant stresses such as rejection. Because transplants are frequently biopsied, they present an opportunity to explore the full spectrum of kidney response-to-wounding from all causes. Defining parenchymal damage in transplanted organs is important for clinical management because it determines function and survival. In this study, we classified the scenarios associated with parenchymal injury in genome-wide microarray results from 1,526 kidney transplant indication biopsies collected during the INTERCOMEX study. We defined injury groups by using archetypal analysis (AA) of scores for gene sets and classifiers previously identified in various injury states. Six groups and their characteristics were defined in this population: No injury, minor injury, two classes of acute kidney injury ("AKI," AKI1, and AKI2), chronic kidney disease (CKD), and CKD combined with AKI. We compared the two classes of AKI, namely, AKI1 and AKI2. AKI1 had a poor function and increased parenchymal dedifferentiation but minimal response-to-injury and inflammation, instead having increased expression of PARD3, a gene previously characterized as being related to epithelial polarity and adherens junctions. In contrast, AKI2 had a poor function and increased response-to-injury, significant inflammation, and increased macrophage activity. In random forest analysis, the most important predictors of function (estimated glomerular filtration rate) and graft loss were injury-based molecular scores, not rejection scores. AKI1 and AKI2 differed in 3-year graft survival, with better survival in the AKI2 group. Thus, injury archetype analysis of injury-induced gene expression shows new heterogeneity in kidney response-to-wounding, revealing AKI1, a class of early transplants with a poor function but minimal inflammation or response to injury, a deviant response characterized as PC3, and an increased risk of failure. Given the relationship between parenchymal injury and kidney survival, further characterization of the injury phenotypes in kidney transplants will be important for an improved understanding that could have implications for understanding native kidney diseases (ClinicalTrials.gov #NCT01299168).
655    _2
$a časopisecké články $7 D016428
700    1_
$a Böhmig, Georg A $u Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria
700    1_
$a Bromberg, Jonathan $u Department of Surgery, University of Maryland, Baltimore, MD, United States
700    1_
$a Einecke, Gunilla $u Department of Nephrology, Hannover Medical School, Hannover, Germany
700    1_
$a Eskandary, Farsad A $u Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria
700    1_
$a Gupta, Gaurav $u Division of Nephrology, Virginia Commonwealth University, Richmond, VA, United States
700    1_
$a Myslak, Marek $u Department of Clinical Interventions, Department of Nephrology and Kidney Transplantation Samodzielny Publiczny Wojewódzki Szpital Zespolony (SPWSZ) Hospital, Pomeranian Medical University, Szczecin, Poland
700    1_
$a Viklicky, Ondrej $u Department of Nephrology and Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Perkowska-Ptasinska, Agnieszka $u Department of Transplantation Medicine, Nephrology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland
700    1_
$a Madill-Thomsen, Katelynn S $u Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada
710    2_
$a INTERCOMEX Investigators
773    0_
$w MED00188756 $t Frontiers in medicine $x 2296-858X $g Roč. 9, č. - (2022), s. 817324
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35463013 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100217 $b ABA008
999    __
$a ind $b bmc $g 1816578 $s 1168651
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 9 $c - $d 817324 $e 20220407 $i 2296-858X $m Frontiers in medicine $n Front. med. $x MED00188756
LZP    __
$a Pubmed-20220718

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...